Search research articles
Contact Us
Filters
Showing results (31-40 of 139) with videos related to
Page
of 14
Sort By:
Blood
|
February 6, 2019
Clinical responses and persistent <i>BRAF</i> V600E<sup>+</sup> blood cells in children with LCH treated with MAPK pathway inhibition
Olive S Eckstein, Johannes Visser, Carlos Rodriguez-Galindo, et al.
Blood Advances
|
August 26, 2020
Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa
Nmazuo W Ozuah, Joseph Lubega, Carl E Allen, et al.
Dermatology Case Reports
|
June 13, 2020
Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis
Daniel J Zinn, Olive Eckstein, Mary L Olsen, et al.
Genes, Chromosomes & Cancer
|
October 16, 2002
Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC
Carl E Allen, Natarajan Muthusamy, Steven E Weisbrode, et al.
Pediatric Blood & Cancer
|
March 11, 2014
Updates on histiocytic disorders
Sarah R Vaiselbuh, Yenan T Bryceson, Carl E Allen, et al.
Blood
|
August 11, 2011
How I treat hemophagocytic lymphohistiocytosis
Michael B Jordan, Carl E Allen, Sheila Weitzman, et al.
Neoplasia (New York, N.Y.)
|
September 25, 2008
Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells
Carl E Allen, Jianguo Du, Bo Jiang, et al.
Blood Advances
|
July 11, 2022
Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAFV600E
Paul Milne, Harshal Abhyankar, Brooks Scull, et al.
Ejhaem
|
November 29, 2023
Mature B-cell lymphomas in adolescents and young adults
Nader Kim El-Mallawany, Lisa Giulino-Roth, John M Burke, et al.
Pediatric Blood & Cancer
|
September 16, 2010
Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality
Tiffany F Lin, Laura L Ferlic-Stark, Carl E Allen, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 139) with videos related to
Sort By:
Page
of 14
Blood
|
February 6, 2019
Clinical responses and persistent <i>BRAF</i> V600E<sup>+</sup> blood cells in children with LCH treated with MAPK pathway inhibition
Olive S Eckstein, Johannes Visser, Carlos Rodriguez-Galindo, et al.
Blood Advances
|
August 26, 2020
Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa
Nmazuo W Ozuah, Joseph Lubega, Carl E Allen, et al.
Dermatology Case Reports
|
June 13, 2020
Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis
Daniel J Zinn, Olive Eckstein, Mary L Olsen, et al.
Genes, Chromosomes & Cancer
|
October 16, 2002
Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC
Carl E Allen, Natarajan Muthusamy, Steven E Weisbrode, et al.
Pediatric Blood & Cancer
|
March 11, 2014
Updates on histiocytic disorders
Sarah R Vaiselbuh, Yenan T Bryceson, Carl E Allen, et al.
Blood
|
August 11, 2011
How I treat hemophagocytic lymphohistiocytosis
Michael B Jordan, Carl E Allen, Sheila Weitzman, et al.
Neoplasia (New York, N.Y.)
|
September 25, 2008
Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells
Carl E Allen, Jianguo Du, Bo Jiang, et al.
Blood Advances
|
July 11, 2022
Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAFV600E
Paul Milne, Harshal Abhyankar, Brooks Scull, et al.
Ejhaem
|
November 29, 2023
Mature B-cell lymphomas in adolescents and young adults
Nader Kim El-Mallawany, Lisa Giulino-Roth, John M Burke, et al.
Pediatric Blood & Cancer
|
September 16, 2010
Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality
Tiffany F Lin, Laura L Ferlic-Stark, Carl E Allen, et al.
Page
of 14